Filing metadata

Accession number
0001209191-22-032672
Form type
Form 4/A
Filer
Quince Therapeutics, Inc.
CIK
CIK 1662774
Filed
May 27, 2022
Reporting period
May 19, 2022
Description
Insider transaction

Explore SEC Filings Hub